[PDF] The Ida Green Room In The Cecil And Ida Green Building eBook

Author : Robert Rakes Shrock
Publisher : MIT Press
Page : 500 pages
File Size : 35,34 MB
Release : 1989
Category : Art
ISBN : 9780262192767

GET BOOK

This warm, anecdotal biography by the Greens' longtime friend, MIT geologist Robert Shrock reveals the human impulses that led to their success, the unique combination of the analytical and the personal that they brought to their business decisions and to their investments in humanity's future.

Author : Robert Rakes Shrock
Publisher : MIT Press
Page : 1106 pages
File Size : 24,83 MB
Release : 1977
Category : Education
ISBN : 9780262192118

GET BOOK

This book completes Professor Shrock's full-scale history of MIT's Geology Department.

Author : Institute of Medicine
Publisher : National Academies Press
Page : 345 pages
File Size : 17,32 MB
Release : 1994-02-01
Category : Medical
ISBN : 0309048907

GET BOOK

Transforming biological discoveries into medical treatment calls for a cadre of health professionals skilled in patient-oriented research. Yet many factors discourage talented persons from choosing clinical research as a profession. This new volume lays out the problem in detail, with specific recommendations to the federal government, the biotechnology and pharmaceutical industries, professional organizations, the health care industry, organized medicine, and the nation's universities and academic health centers. The volume explores How clinical research is conducted, what human resources are available, and what research opportunities lie ahead. Why health professionals become discouraged about clinical research. How the educational system has failed in this area and what programs stand out as models. How funding affects the supply of researchers. This practical book will be of immediate interest to public and private agencies funding research, research administrators, medical educators, health professionals, and those pursuing a career in clinical investigation.

Author : Institute of Medicine
Publisher : National Academies Press
Page : 535 pages
File Size : 19,98 MB
Release : 1996-12-04
Category : Medical
ISBN : 0309054427

GET BOOK

The "contraceptive revolution" of the 1960s and 1970s introduced totally new contraceptive options and launched an era of research and product development. Yet by the late 1980s, conditions had changed and improvements in contraceptive products, while very important in relation to improved oral contraceptives, IUDs, implants, and injectables, had become primarily incremental. Is it time for a second contraceptive revolution and how might it happen? Contraceptive Research and Development explores the frontiers of science where the contraceptives of the future are likely to be found and lays out criteria for deciding where to make the next R&D investments. The book comprehensively examines today's contraceptive needs, identifies "niches" in those needs that seem most readily translatable into market terms, and scrutinizes issues that shape the market: method side effects and contraceptive failure, the challenge of HIV/AIDS and other sexually transmitted diseases, and the implications of the "women's agenda." Contraceptive Research and Development analyzes the response of the pharmaceutical industry to current dynamics in regulation, liability, public opinion, and the economics of the health sector and offers an integrated set of recommendations for public- and private-sector action to meet a whole new generation of demand.

Author : Committee on Health Effects Associated with Exposures During the Gulf War
Publisher : National Academies Press
Page : 426 pages
File Size : 24,87 MB
Release : 2000-12-12
Category : Medical
ISBN : 0309171628

GET BOOK

The men and women who served in the Gulf War theater were potentially exposed to a wide range of biological and chemical agents. Gulf War and Health: Volume 1 assesses the scientific literature concerning the association between these agents and the adverse health effects currently experienced by a large number of veterans.

Author : Institute of Medicine
Publisher : National Academies Press
Page : 127 pages
File Size : 44,31 MB
Release : 1999-10-19
Category : Medical
ISBN : 0309172608

GET BOOK

In response to a request by the Health Care Financing Administration (HCFA), the Institute of Medicine proposed a study to examine definitions of serious or complex medical conditions and related issues. A seven-member committee was appointed to address these issues. Throughout the course of this study, the committee has been aware of the fact that the topic addressed by this report concerns one of the most critical issues confronting HCFA, health care plans and providers, and patients today. The Medicare+Choice regulations focus on the most vulnerable populations in need of medical care and other services-those with serious or complex medical conditions. Caring for these highly vulnerable populations poses a number of challenges. The committee believes, however, that the current state of clinical and research literature does not adequately address all of the challenges and issues relevant to the identification and care of these patients.

Author : Institute of Medicine
Publisher : National Academies Press
Page : 279 pages
File Size : 16,99 MB
Release : 1995-03-14
Category : Medical
ISBN : 0309176611

GET BOOK

In June 1993 a clinical trial of fialuridine (FIAU), a promising new medication for hepatitis B, was abruptly terminated when one of the 15 out-patients participating in the National Institutes of Health (NIH) study was suddenly hospitalized with liver failure. Although all the remaining patients were contacted and told to stop taking their medication, six more subsequently developed severe toxicity. Five patients died, and two others were probably saved from death only by having liver transplants. In response to a request from the Secretary of the Department of Health and Human Services, the IOM committee has analyzed the FIAU clinical trials, making recommendations for additional safeguards for the conduct of future clinical trials. This evaluation included the review of documents pertaining to investigational new drug submissions, protocols and consent forms from other clinical trials, as well as information available from other clinical and preclinical experience with compounds related to FIAU and its parent drug, fiacitibine (FIAC), which is metabolized to FIAU. The committee does not seek to affix responsibility for the adverse outcome of this NIH trial, but instead focuses on whether any rules or procedures governing the clinical trials process itself need to be changed, and if so, what burdens or costs such changes might place on future clinical trials.

Author : National Research Council
Publisher : National Academies Press
Page : 176 pages
File Size : 28,20 MB
Release : 2000-10-09
Category : Medical
ISBN : 0309071917

GET BOOK

One of the barriers to improving the quality of cancer care in the United States is the inadequacy of data systems. Out-of-date or incomplete information about the performance of doctors, hospitals, health plans, and public agencies makes it hard to gauge the quality of care. Augmenting today's data systems could start to fill the gap. This report examines the strengths and weaknesses of current systems and makes recommendations for enhancing data systems to improve the quality of cancer care. The board's recommendations fall into three key areas: Enhance key elements of the data system infrastructure (i.e., quality-of-care measures, cancer registries and databases, data collection technologies, and analytic capacity). Expand support for analyses of quality of cancer care using existing data systems. Monitor the effectiveness of data systems to promote quality improvement within health systems.